Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05210855
Other study ID # NIMAO/2020-1/NM-02
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2022
Est. completion date September 2022

Study information

Verified date January 2022
Source Centre Hospitalier Universitaire de Nimes
Contact Djamel Dabli
Phone 04.66.68.33.10
Email djamel.dabli@chu-nimes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Head trauma is a frequent reason for consultation in the emergency room. The CT scan is the reference examination allowing rapid management of the patient. However, CT examinations are among the diagnostic examinations with the highest exposure to ionizing radiation. The study investigators have previously implemented "ultra-low dose" (ULD) acquisitions for several pathologies with an effective dose level similar to that of a standard radiographic examination. These ULD acquisitions are now routinely used in our clinical practice for explorations of the thorax, spine, pelvis and proximal femurs, extremities. This study expands these ULD acquisitions to skull CT for detecting traumatic intracranial lesions. The study investigators hypothesize that it would be possible to search for intracranial lesions in patients with head trauma using ULD protocols, thereby reducing the doses delivered to the patient while maintaining sufficient image quality for the diagnosis.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 77
Est. completion date September 2022
Est. primary completion date September 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient presenting to the emergency room of the CHU of Nîmes for a cranial trauma requiring scanning. - Patient with isolated head injury or polytrauma patient with head injury among others. - The patient or their legal representative or family member must have given their free and informed consent and signed the consent form, or the patient was included under an emergency situation - The patient must be a member or beneficiary of a health insurance plan Exclusion Criteria: - The subject is participating in a study prohibiting participation in other studies, or is in a period of exclusion determined by a previous study - Patient is pregnant, parturient or breastfeeding

Study Design


Intervention

Diagnostic Test:
CT scan
Scan with classic dose followed by ultra-low dose

Locations

Country Name City State
France CHU de Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Image quality of ultra-low dose scan compared to classic dose for visualising the differentiation of grey/white matter 5-point scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Primary Image quality of ultra-low dose scan compared to classic dose for visualising lenticular nuclei 5-point scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Primary Image quality of ultra-low dose scan compared to classic dose for visualising the ventricular system 5-point scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Primary Image quality of ultra-low dose scan compared to classic dose for visualising basal cisterns 5-point scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Primary Image quality of ultra-low dose scan compared to classic dose for visualising deconvexed subarachnoid spaces 5-point scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Secondary Inter-evaluator concordance (senior versus junior) in visualizing all five structures (differentiation of grey/white matter, lenticular nuclei, ventricular system, basal cisterns, deconvexed subarachnoid spaces) Total score of the 5 Likert scores Day 0
Secondary Presence of at least one extradural hematoma by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one subarachnoid hemorrhage by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one subdural hematoma by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one intraparenchymal hemorrhage by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one intracranial hemorrhage by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one cranial bone lesion by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Presence of at least one bone lesion by ultra-low dose versus classical scanner Yes/no Day 0
Secondary Radiologist-reported image quality of ultra-low dose versus classical scanner 4-point Likert scale: Interpretable, interpretable despite moderate technical issues (centering, movement, constant), entirely interpretable despite moderate technical issues (centering, movement, constant), No technical issues Day 0
Secondary Radiologist-reported diagnostic quality of ultra-low dose versus classical scanner 4-point Likert scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Secondary Radiologist-reported confidence level of ultra-low dose versus classical scanner 4-point Likert scale: unacceptable, sub-optimal, acceptable, better than average Day 0
Secondary Interpretation time of ultra-low dose versus classical scanner for a senior and junior evaluator Minutes Day 0
See also
  Status Clinical Trial Phase
Completed NCT03674398 - Aerobic Exercise and Cognitive Training Effects on Postconcussive Symptomology N/A
Recruiting NCT04279431 - Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One
Completed NCT00531258 - TMS in the Treatment of the Sequelae of Closed Brain Injury N/A
Recruiting NCT00213174 - Study of Sand Versus Wood Chip Surfaces on School Playgrounds to Minimize Injury in School Children Phase 3
Recruiting NCT04230577 - Photobiomodulation to Improve Cognition in TBI, With fMRI Early Phase 1